BrightGene Bio-Medical Technology Dividend
Dividend criteria checks 1/6
BrightGene Bio-Medical Technology is a dividend paying company with a current yield of 0.37% that is well covered by earnings.
Key information
0.4%
Dividend yield
21%
Payout ratio
| Industry average yield | 1.8% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Earnings per share | CN¥0.47 |
| Dividend yield forecast in 3Y | n/a |
Recent dividend updates
No updates
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Whilst dividend payments have been stable, 688166 has been paying a dividend for less than 10 years.
Growing Dividend: 688166's dividend payments have increased, but the company has only paid a dividend for 4 years.
Dividend Yield vs Market
| BrightGene Bio-Medical Technology Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (688166) | 0.4% |
| Market Bottom 25% (CN) | 0.6% |
| Market Top 25% (CN) | 2.4% |
| Industry Average (Pharmaceuticals) | 1.8% |
| Analyst forecast in 3 Years (688166) | n/a |
Notable Dividend: 688166's dividend (0.37%) isn’t notable compared to the bottom 25% of dividend payers in the CN market (0.65%).
High Dividend: 688166's dividend (0.37%) is low compared to the top 25% of dividend payers in the CN market (2.35%).
Earnings Payout to Shareholders
Earnings Coverage: With its low payout ratio (20.7%), 688166's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: 688166 is paying a dividend but the company has no free cash flows.